Patents by Inventor Patrick O'Mullan

Patrick O'Mullan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
    Patent number: 8652789
    Abstract: A method is provided for the diagnosis or prognosis of a disease state, involving the measurement of a parameter of discriminated dipeptidyl dipeptidases from a patient sample, and the correlation of the parameter with a disease.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: February 18, 2014
    Assignee: Becton, Dickinson and Company
    Inventors: Patrick O'Mullan, Craig A. Gelfand
  • MODULATION OF FERMENTATION PRODUCTS THROUGH VITAMIN SUPPLEMENTATION
    Publication number: 20120107888
    Abstract: Improved yields of biofuels and other chemicals are obtained by culturing a cellulolytic microorganism, such as Clostridium phytofermentans, Clostridium sp. Q.D, or Clostridium biocatalysts thereof in modulated amounts of vitamins, such as thiamine or nicotinic acid. Provided are methods to increase yields of ethanol and other fermentation products through vitamin supplementation. Recombinant microorganisms with altered metabolic pathways that obviate the need to modulate media components during hydrolysis and fermentation of biomass are also described.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 3, 2012
    Applicant: Qteros, Inc.
    Inventors: Matthias Schmalisch, William G. Latouf, Brandon Wolner, Patrick O'Mullan
  • BIOCATALYSTS SYNTHESIZING DEREGULATED CELLULASES
    Publication number: 20120064592
    Abstract: Provided are isolated novel Clostridium phytofermentans biocatalysts with deregulated cellulase activity that produce high yields of products. Further provided are methods of using the biocatalysts to degrade organic material and for use in industrial processes.
    Type: Application
    Filed: October 10, 2011
    Publication date: March 15, 2012
    Applicant: Qteros, Inc.
    Inventors: Patrick O'Mullan, Jase Patel, Matthias Schmalisch, Branden Wolner, Philippa Reeder
  • REDIRECTED BIOENERGETICS IN RECOMBINANT CELLULOLYTIC CLOSTRIDIUM MICROORGANISMS
    Publication number: 20110269201
    Abstract: Compositions and methods are provided for redirecting metabolic solventogenesis pathways to enhance the product yield from fermentation of biomass. Clostridium microorganism pathways are modified to extend the growth phase and prevent inhibition of acetaldehyde while bypassing the synthesis of acetyl CoA.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 3, 2011
    Applicant: Qteros, Inc.
    Inventors: Kevin Gray, Patrick O'Mullan
  • Diagnosis and prognosis of dipeptidyl peptidase-associated disease states
    Publication number: 20070264671
    Abstract: A method is provided for the diagnosis or prognosis of a disease state, involving the measurement of a parameter of discriminated dipeptidyl dipeptidases from a patient sample, and the correlation of the parameter with a disease.
    Type: Application
    Filed: March 13, 2007
    Publication date: November 15, 2007
    Applicant: Becton, Dickinson and Company
    Inventors: Patrick O'Mullan, Craig Gelfand